TrialBritish journal of cancer2017

Second-line pazopanib in patients with relapsed and refractory small-cell lung cancer: a multicentre phase II study of the Hellenic Oncology Research Group.

F Koinis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.